0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query delveinsight familial hypercholesterolemia type ii hyperlipoproteinemia api insights 2014.Your search for "" gave back 1533248 results.
Hypercholesterolemia (Metabolic Disorder) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...
Catalog:
Global Markets Direct
October 2021
Price: USD 2,000.00
Hypercholesterolemia - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
November 2020
Price: USD 2,000.00
Hypercholesterolemia - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,000.00
Hypercholesterolemia is a genetic disorder characterized by very high levels of cholesterol in the blood. Hypercholesterolemia, also termed as...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Hypercholesterolemia is a genetic disorder characterized by very high levels of cholesterol in the blood. Hypercholesterolemia, also termed as...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Hypercholesterolemia is a genetic disorder characterized by very high levels of cholesterol in the blood. Hypercholesterolemia, also termed as...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Familial Chylomicronemia (Type I Hyperlipoproteinemia) (Metabolic Disorders) - Drugs in Development, 2021 Summary Familial Chylomicronemia (Type I...
Catalog:
Global Markets Direct
April 2021
Price: USD 2,000.00
Familial Chylomicronemia (Type I Hyperlipoproteinemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary...
Catalog:
Global Markets Direct
May 2022
Price: USD 2,000.00
The “Homozygous Familial Hypercholesterolemia Epidemiology Industry Forecast” looks at past sales and reviews total world Homozygous Familial...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Market Analysis and Insights: Global Homozygous Familial Hypercholesterolemia Epidemiology Market The global Homozygous Familial Hypercholesterolemia...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Heterozygous Familial Hypercholesterolemia Drug market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Homozygous Familial Hypercholesterolemia Treatment market is projected to grow from US$ million in 2023 to US$ million by 2029, at a...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Highlights The global Homozygous Familial Hypercholesterolemia Treatment market was valued at US$ million in 2022 and is anticipated to reach US$...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Highlights The global Heterozygous Familial Hypercholesterolemia Drug market was valued at US$ million in 2022 and is anticipated to reach US$...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Highlights The global Homozygous Familial Hypercholesterolemia Epidemiology market was valued at US$ million in 2022 and is anticipated to reach US$...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
